Literature DB >> 12203049

Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms --a study using IBZM-SPECT.

D Ebert1, T Klein, C Lohrmann, L Tebartz van Elst, B Hesslinger, F D Juengling.   

Abstract

Ten male patients with type I alcohol dependency fulfilling DSM-IV criteria for alcohol dependency were investigated twice using IBZM-SPECT after alcohol withdrawal (day 2 and day 28 after withdrawal). Five patients had a history of physical withdrawal symptoms, 5 patients had no such history. The group with physical withdrawal symptoms showed higher IBZM binding in both scans indicating differences of dopaminergic neurotransmission in different subtypes of alcohol dependency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203049     DOI: 10.1007/s00702-002-0749-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  4 in total

Review 1.  Alcohol and basal ganglia circuitry: Animal models.

Authors:  David M Lovinger; Veronica A Alvarez
Journal:  Neuropharmacology       Date:  2017-03-21       Impact factor: 5.250

2.  Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics.

Authors:  Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean O'Connor; Christine M Herring
Journal:  Synapse       Date:  2010-12-08       Impact factor: 2.562

Review 3.  Perspectives on fronto-fugal circuitry from human imaging of alcohol use disorders.

Authors:  Natalie M Zahr; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

4.  Selective alterations of brain dopamine D(2) receptor binding in cirrhotic patients: results of a (11)C-N-methylspiperone PET study.

Authors:  Yuki Watanabe; Akinobu Kato; Kei Sawara; Roger F Butterworth; Toshiaki Sasaki; Kazunori Terasaki; Koichiro Sera; Kazuyuki Suzuki
Journal:  Metab Brain Dis       Date:  2008-08-07       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.